A man is administered with Russia’s Sputnik V vaccine in Algiers on February 3, 2021. Photo: AP A man is administered with Russia’s Sputnik V vaccine in Algiers on February 3, 2021. Photo: AP
A man is administered with Russia’s Sputnik V vaccine in Algiers on February 3, 2021. Photo: AP

Coronavirus: Russia eyes German firm as co-partner in Sputnik V vaccine production

  • Call to Germany’s IDT Biologika comes a day after The Lancet journal published trial results showing Sputnik V to be 91.6 per cent effective against Covid-19
  • Sputnik V has been approved in more than 15 countries, including several ex-Soviet republics, but also Argentina, Tunisia and Pakistan

Topic |   Coronavirus pandemic
A man is administered with Russia’s Sputnik V vaccine in Algiers on February 3, 2021. Photo: AP A man is administered with Russia’s Sputnik V vaccine in Algiers on February 3, 2021. Photo: AP
A man is administered with Russia’s Sputnik V vaccine in Algiers on February 3, 2021. Photo: AP
READ FULL ARTICLE